Wide Ranks

ATNF

180 Life Sciences Corp.

2.19

Top Statistics
Market Cap 4 M Forward PE -4.76 Revenue Growth 0.00 %
Current Ratio 0.58 Trailing PE 0.2744 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -0.1950 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 1 M Total Cash Per Share 1.18 Total Debt 442285
Total Debt To Equity Current Ratio 0.58 Book Value Per Share -0.2390
All Measures
Short Ratio 3.00 % Message Board Id finmb_587644367 Shares Short Prior Month 73286
Return On Equity -3.99 City Palo Alto Uuid 556dc907-19b7-3c23-912e-861728bdcf7c
Previous Close 2.20 First Trade Date Epoch Utc 1 B Book Value -0.2390
Beta 0.2470 Total Debt 442285 Volume 63331
Last Split Date 1 B Fifty Two Week Low 1.16 Total Cash Per Share 1.18
Shares Short Previous Month Date 1 B Max Age 86400 Sand P52 Week Change 0.3133
Net Income To Common -12550828 Short Percent Of Float 0.1368 Implied Shares Outstanding 1 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 77260
Average Volume10days 77260 Total Cash 1 M Next Fiscal Year End 1 B
Held Percent Insiders 0.0434 Trailing PE 0.2744 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 2.20 Target Low Price 0.0000
Gmt Off Set Milliseconds -18000000 Fifty Day Average 2.72 Open 2.13
Free Cashflow -4449469 State CA Dividend Yield 0.00 %
Return On Assets -0.6350 Time Zone Short Name EST Trailing Eps 7.98
Day Low 2.13 Address1 Building 4 Shares Outstanding 1 M
Price Hint 4 Target High Price 0.0000 Website https://180lifesciences.com
52 Week Change -0.5747 Average Volume 1 M Forward Eps -0.4600
Recommendation Key none Compensation As Of Epoch Date 1 B Quick Ratio 28.80 %
Last Split Factor 1:19 Regular Market Day High 2.36 Is_sp_500 False
Profit Margins 0.00 % Fifty Two Week High 17.75 Day High 2.36
Shares Short 139425 Regular Market Open 2.13 Industry Key biotechnology
Earnings Growth 0.00 % Revenue Growth 0.00 % Shares Percent Shares Out 0.1358
Operating Cashflow -4241737 Currency USD Time Zone Full Name America/New_York
Market Cap 4 M Is_nasdaq_100 False Zip 94306
Quote Type EQUITY Industry Biotechnology Long Name 180 Life Sciences Corp.
Regular Market Day Low 2.13 Held Percent Institutions 0.0345 Current Price 2.19
Address2 Suite 200 3000 El Camino Real Enterprise To Ebitda -0.1950 Financial Currency USD
Current Ratio 0.58 Industry Disp Biotechnology Country United States
Float Shares 838977 Two Hundred Day Average 2.34 Enterprise Value 1 M
Forward PE -4.76 Regular Market Volume 63331 Ebitda -8826971
Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
180 Life Sciences Corp.

, a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases.

The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed phase 2a and phase 2b proof-of-concept clinical trials for early-stage Dupuytren's Contracture; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, that focuses on alpha 7 nicotinic acetylcholine receptor.

The company is headquartered in Palo Alto, California.